Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
5.13
+0.32 (6.65%)
At close: May 12, 2025, 4:00 PM
4.880
-0.250 (-4.87%)
After-hours: May 12, 2025, 6:40 PM EDT
Cogent Biosciences Market Cap
Cogent Biosciences has a market cap or net worth of $584.48 million as of May 12, 2025. Its market cap has decreased by -6.53% in one year.
Market Cap
584.48M
Enterprise Value
355.91M
1-Year Change
-6.53%
Ranking
Category
Stock Price
$5.13
Market Cap Chart
Since July 10, 2020, Cogent Biosciences's market cap has increased from $124.27M to $584.48M, an increase of 370.33%. That is a compound annual growth rate of 37.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 548.02M | -36.40% |
| Dec 31, 2024 | 861.60M | 70.14% |
| Dec 29, 2023 | 506.41M | -37.32% |
| Dec 30, 2022 | 807.97M | 136.30% |
| Dec 31, 2021 | 341.92M | -2.42% |
| Dec 31, 2020 | 350.40M | 181.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |